(Q33979763)

English

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Markolf Hanefeld

3

object named as

Markolf Hanefeld

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Andreas Pfützner

1

object named as

Andreas Pfützner

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Thomas Schöndorf

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Thomas Forst

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Journal of Diabetes Science and Technology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

706-716

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Changes in C-reactive protein from low-fat diet and/or physical activity in men and women with and without metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Human C-reactive protein and the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Interrelationships between inflammation, C-reactive protein, and insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

The link between abdominal obesity, metabolic syndrome and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

C-reactive protein: a new risk assessment tool for cardiovascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Inflammatory markers and the risk of coronary heart disease in men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

C-reactive protein: risk marker or mediator in atherothrombosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

C-reactive protein and risk of cardiovascular disease: evidence and clinical application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

C-reactive protein and other inflammatory risk markers in acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Inflammatory pathways in atherosclerosis and acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Generation of C-reactive protein and complement components in atherosclerotic plaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

5 July 2018

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Novel inflammatory markers of coronary risk: theory versus practice.

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study.

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim study

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Intensive Insulin Therapy Exerts Antiinflammatory Effects in Critically Ill Patients and Counteracts the Adverse Effect of Low Mannose-Binding Lectin Levels

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Weight loss reduces C-reactive protein levels in obese postmenopausal women

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Physical activity, coronary heart disease, and inflammatory response

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

29 October 2018

Elevated C-reactive protein levels in overweight and obese adults

2 references

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901049

29 October 2018

Effect of Rosiglitazone on Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome

1 reference

https://api.crossref.org/works/10.1177%2F193229681000400326

21 January 2018

Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20513338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/193229681000400326

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33979763&oldid=1609307570"